We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+1.64%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$726M
AUM Growth
+$25.3M
Cap. Flow
+$18.4M
Cap. Flow %
2.53%
Top 10 Hldgs %
78.07%
Holding
26
New
–
Increased
9
Reduced
7
Closed
1

Top Buys

Rank Stock Value
1
PGEN icon
Precigen
PGEN
+$11.6M
2
NXTM
NxStage Medical Inc.
NXTM
+$10.8M
3
VRML
Vermillion, Inc.
VRML
+$10.6M
4
BIOL
Biolase, Inc.
BIOL
+$6.59M
5
TSRO
TESARO, Inc.
TSRO
+$3.38M

Top Sells

Rank Stock Value
1
MAKO
MAKO SURGICAL CORP COM
MAKO
+$23.9M
2
THOR
THORATEC CORPORATION
THOR
+$6.42M
3
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.18M
4
ACOR
Acorda Therapeutics
ACOR
+$1.07M
5
OPK icon
Opko Health
OPK
+$768K

Sector Composition

Rank Sector Weight
1 Healthcare 68.42%
2 Consumer Staples 0.29%
3 Financials 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QDEL icon
1
QuidelOrtho
QDEL
$1.14B
$101M 13.89%
3,265,457
– –
THOR
2
DELISTED
THORATEC CORPORATION
THOR
$75.9M 10.44%
2,072,700
-163,649
-7% -$6.42M
THC icon
3
Tenet Healthcare
THC
$22.6B
$74M 10.18%
1,755,950
– –
MZOR
4
DELISTED
Mazor Robotics Ltd.
MZOR
$62.7M 8.63%
3,213,274
– –
AXDX
5
DELISTED
Accelerate Diagnostics
AXDX
$57.9M 7.97%
474,859
+9,408
+2% +$1.26M
ACOR
6
DELISTED
Acorda Therapeutics
ACOR
$57.1M 7.86%
16,303
-275
-2% -$1.07M
OPK icon
7
Opko Health
OPK
$1.25B
$48.4M 6.67%
5,738,742
-76,000
-1% -$768K
NXTM
8
DELISTED
NxStage Medical Inc.
NXTM
$34.1M 4.69%
3,410,067
+947,754
+38% +$10.8M
ARAY icon
9
Accuray
ARAY
$29M
$28.2M 3.88%
3,240,006
+371,581
+13% +$2.88M
HNSN
10
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$27.9M 3.84%
1,641,743
– –
TTHI
11
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$24.4M 3.36%
4,287,412
– –
TSRO
12
DELISTED
TESARO, Inc.
TSRO
$21.7M 2.99%
768,219
+91,107
+13% +$3.38M
GTIV
13
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
$19.5M 2.69%
1,572,398
-10,020
-0.6% -$121K
VRML
14
DELISTED
Vermillion, Inc.
VRML
$16.6M 2.29%
7,139,960
+4,339,980
+155% +$10.6M
PACB icon
15
Pacific Biosciences
PACB
$432M
$13.5M 1.85%
2,575,729
+614,041
+31% +$2.82M
PGEN icon
16
Precigen
PGEN
$1.97B
$13.4M 1.84%
587,478
+574,922
+4,579% +$11.6M
IRWD icon
17
Ironwood Pharmaceuticals
IRWD
$626M
$12.6M 1.73%
1,290,720
-29,850
-2% -$268K
WBMD
18
DELISTED
WebMD Health Corp.
WBMD
$11.9M 1.63%
300,141
+77,629
+35% +$2.8M
BIOL
19
DELISTED
Biolase, Inc.
BIOL
$11.4M 1.57%
325
+278
+591% +$6.59M
MAKO
20
DELISTED
MAKO SURGICAL CORP COM
MAKO
$4.54M 0.63%
151,398
-802,115
-84% -$23.9M
BIIB icon
21
Biogen
BIIB
$30.4B
$3.24M 0.45%
11,603
– –
AGEN
22
Agenus
AGEN
$275M
$3.24M 0.45%
62,446
– –
YTEN
23
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2.09M 0.29%
29
– –
ONCT
24
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$821K 0.11%
356
-261
-42% -$597K
LTS
25
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$522K 0.07%
166,849
– –
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Oracle Investment Management held 26 positions worth $726M, up 3.6% from $701M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 3.8%. Oracle Investment Management opened no new positions and exited 1, leaving the 26-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, up from 66% a quarter earlier, followed by Consumer Staples and Financials.

  • Oracle Investment Management added most to Precigen in Q4 2013, an estimated $11.6M increase.
  • Oracle Investment Management's biggest Q4 2013 reduction was MAKO SURGICAL CORP COM, cutting an estimated $23.9M.
  • Oracle Investment Management fully exited AVEO Pharmaceuticals, Inc. in Q4 2013, selling an estimated $1.18M.
  • Oracle Investment Management's ten largest holdings make up 78% of its $726M portfolio in Q4 2013.
  • Oracle Investment Management opened 0 new positions and closed 1 in Q4 2013.
  • Oracle Investment Management's portfolio value rose 3.6% quarter-over-quarter to $726M.

Based on Oracle Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.